Nv. Bergasa et al., EFFECTS OF NALOXONE INFUSIONS IN PATIENTS WITH THE PRURITUS OF CHOLESTASIS - A DOUBLE-BLIND, RANDOMIZED, CONTROLLED TRIAL, Annals of internal medicine, 123(3), 1995, pp. 161-167
Objective: To determine whether endogenous opioids contribute to the p
ruritus of cholestasis by studying the effect of the opiate antagonist
naloxone on the perception of pruritus and on scratching activity in
patients with this form of pruritus. Design: Double-blind, placebo-con
trolled, crossover trial with four periods. Setting: Clinical research
referral center. Patients: 29 pruritic patients with liver diseases o
f various causes. Intervention: Each patient received as many as two n
aloxone and two placebo solution infusions consecutively in random ord
er. Each infusion lasted 24 hours.Measurements: During the infusions,
visual analog scores of pruritus were recorded every 4 hours while pat
ients were awake; scratching activity independent of limb movements wa
s recorded continuously. Results: One patient had a mild reaction cons
istent with a naloxone-precipitated syndrome similar to opiate withdra
wal. A significant 24-hour rhythm of scratching activity was seen in 7
of 11 patients for whom complete 96-hour data were collected. The mea
n of a visual analog score of the perception of pruritus (maximum, 10.
0) recorded during naloxone infusions was 0.582 lower than that record
ed during placebo infusions (95% CI, 0.176 to 0.988; P < 0.01). Furthe
rmore, the ratio of the geometric mean hourly scratching activity duri
ng naloxone infusions to that during placebo infusions was 0.727 (CI,
0.612 to 0.842; P < 0.001) and was greater than 1.0 in only five patie
nts. Conclusions: Naloxone administration is associated with ameliorat
ion of the perception of pruritus and reduction of scratching activity
in cholestatic patients. Because of the opioid receptor specificity o
f the action of naloxone, these findings support the hypothesis that a
mechanism underlying the pruritus of cholestasis is modulated by endo
genous opioids and suggest that opiate antagonists may have a role in
the management of this complication of cholestasis.